Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D).
Dementia, a condition that slowly makes it harder for people to remember things and think clearly, occurs when brain cells are damaged and their connections stop working properly. This damage, which worsens over time, can be caused by various modifiable factors, including obesity, T2D,…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply